Peter Spaeth

Peter Spaeth

WilmerHale

Contact
View Bio
RSS

Latest Posts › Abbreviated New Drug Application (ANDA)

Share:

FDA Publishes List of Drug Companies Accused of Hindering Generic Entry: Antitrust Implications

Today, as part of the Trump Administration's stated goal to lower drug prices, the Food and Drug Administration (FDA) published a list of pharmaceutical companies that have allegedly refused to sell samples of their drugs to...more

5/18/2018  /  Abbreviated New Drug Application (ANDA) , Antitrust Provisions , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Generic Drugs , Hatch-Waxman , Pharmaceutical Industry , REMS , Sherman Act , The Clayton Act
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide